Solutions
Orion® Molecular Design
Web-Access Platform
Cloud-Native Architecture
Small Molecule Discovery Suite
Commercially Available Compounds
Lead Discovery
Large Scale Virtual Screening
Shape Searching (ROCS)
Shape Searching GPU (FastROCS)
Docking (OEDocking)
Binding Site Comparison (SiteHopper)
Lead Optimization
Shape Searching (ROCS)
Free Energy Calculation (NES)
Electrostatic Similarity (EON)
Fragment Replacement (BROOD)
Ligand Pose Prediction (POSIT)
Ligand Modification (GAMEPLAN)
Ligand Entropy (FREEFORM)
Quantun Calculations (Psi4-based)
pKa Prospector
Biomodeling
Protein Preparation (SPRUCE)
Binding Site Comparison (SiteHopper)
Crystallography (AFITT)
Molecular Data Preparation
Property Calculator (FILTER)
Conformer Generation (OMEGA)
Tautomer and Charge (QUACPAC)
Toolkit Development Platform
Cheminformatics
Molecular Similarity (GraphSim TK)
Chemical Representation (OEChem TK)
Modeling
OpenEye Consulting
Drug Discovery Services
Crystal Structure Prediction
Method Development and Coding
Partnerships
Available Databases
Commercially Available Compound Databases
Prepared Protein Structure Database (MMDS)
Iridium Database
pKa Database
Conformational Databases
Visualizer and Data Analysis
Web-based Visualizer and Analysis (Orion)
Desktop Visualizer (VIDA)
Business
Licensing Philosophy
Pricing
Academic Licensing
Request Evaluation
Science
Publications
Presentations
Webinars
Blogs
CUP Events
SAMPL
Support
Documentation
Downloads
Platforms
Report A Bug
About
News
Events
Philosophy
Board of Directors
Staff
Careers
Contact Us
Privacy Policy
Subscribe
Careers
Click To Search
Ant's Rants
View Items In A Gallery View
Frank Brown - In Memoriam
Dave Weininger's passing
CD and MD - Molecular Dynamics
A Different Conference
On the Passing of Andrew Grant
Curing Pharma: (1) Avoiding Hype-based Science
What Is Really Killing Pharma
The Bayh-Dole Act
The Rant Goes On…
Ant's Rant - The First of Many
Recent Blog Articles
Frank Brown - In Memoriam
Read More
Dave Weininger's passing
Read More
CD and MD - Molecular Dynamics
Read More
